Same Indication

Ipilimumab vs Levodopa

Ipilimumab vs Levodopa: Overview

This comparison examines the pharmacological differences between Ipilimumab and Levodopa.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Levodopa: Metabolic precursor of dopamine that crosses the BBB.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Levodopa — 1.5 hours.

Chemical Properties

Molecular Formula: Levodopa — C9H11NO4.

Molecular Weight: Levodopa — 197.1880 g/mol.

Type: Ipilimumab — Antibody; Levodopa — Small molecule.